Table 1.
Name | Enrichment Technique | Type (Physical or Biological) | Key Findings |
---|---|---|---|
Herringbone (HB)-Chip | Surface affinity | Biological | CTCs were detected in 93% of patients with metastatic disease [13]. |
Nano Velcro | Cell affinity | Biological | Capable of detecting, isolating, and purifying CTCs from blood samples with high efficiency for subsequent molecular analyses [28,29]. |
Nanoparticle-herringbone microfluidic chip (NP-HBCTC-Chip) | Surface affinity | Biological | Enhanced capture efficiency and recovery of isolated CTCs [30]. |
PEDOT Nano Velcro Chips |
Cell affinity | Biological | Ability to achieve high cell purity as well as preserve the integrity of RNA transcripts from the purified cells [31]. |
CaTCh FISH | Magnetic separation/fluorescence in situ hybridization |
Physical | Capture CTCs for in situ RNA analysis [32,33]. |
Two-stage microfluidic chip | Size and asymmetry based capturing |
Physical | High rate (99%) CTC clusters recovery with 87% viability [34,35]. |
Bait-trap chip | In situ rolling circle amplification (RCA) method | Physical | Accurate and ultrasensitive capture of live CTCs from peripheral blood [35]. |
3D Palladium Filter | Lithography plus electroforming process | Physical | Enumeration and isolation of CTCs for genetic analysis [36]. |
Pillar-X | Bimodular microfluidic device | Biophysical | Efficiently captures both single cells and clusters and sorts them based on size, cohesiveness, and epithelial identity [37]. |
Dielectrophoretic field-flow-fractionation (DEP-FFF) | Batch-mode microfluidic di-electrophoresis method | Physical | 70–75% capture efficiency [38,39]. |
Parsortix™ Cell Separation System |
Microfluidic particle separation technology | Biophysical | High capture efficiency and viable CTCs for downstream analyses [40]. |